Matthew Spector
Clinical trials sponsored by Matthew Spector, explained in plain language.
-
New drug combo aims to spare voice box in advanced throat cancer
Disease control Recruiting nowThis study tests whether adding the immunotherapy drug toripalimab to standard chemotherapy can help control advanced laryngeal or hypopharyngeal cancer while avoiding removal of the voice box (laryngectomy). About 87 adults with stage III-IV disease that is surgically removable …
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Glowing dye during throat surgery may slash leak risk
Disease control Recruiting nowThis study tests whether using a special dye and camera during throat surgery can help surgeons see and remove poorly blood-supplied tissue, reducing the chance of a painful leak called pharyngocutaneous fistula. About 225 adults with throat cancer who have had prior radiation wi…
Phase: PHASE2 • Sponsor: Matthew Spector • Aim: Disease control
Last updated May 13, 2026 16:02 UTC